We are live on ! Find out more
JSC

Jackson Square Capital Portfolio holdings

AUM $719M
1-Year Est. Return 144.18%
This Fund
S&P 500
This Quarter Est. Return
-1.76%
1 Year Est. Return
+144.18%
3 Year Est. Return
+415.93%
5 Year Est. Return
+613.77%
10 Year Est. Return
AUM
$205M
AUM Growth
-$31.7M
Cap. Flow
-$25.1M
Cap. Flow %
-12.26%
Top 10 Hldgs %
37.46%
Holding
155
New
17
Increased
33
Reduced
54
Closed
33

Top Buys

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$4.43M
2
GFS icon
GlobalFoundries
GFS
+$2.27M
3
ADI icon
Analog Devices
ADI
+$1.46M
4
TGT icon
Target
TGT
+$1.34M
5
SYK icon
Stryker
SYK
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 32.36%
2 Healthcare 21.13%
3 Energy 9.75%
4 Consumer Discretionary 9.44%
5 Financials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NICE icon
26
Nice
NICE
$5.29B
$2.52M 1.23%
13,406
+5,174
+63% +$1.08M
DG icon
27
Dollar General
DG
$25.9B
$2.43M 1.19%
10,134
-156
-2% -$38.5K
SNOW icon
28
Snowflake
SNOW
$92.9B
$2.29M 1.12%
13,468
-9,440
-41% -$1.56M
NET icon
29
Cloudflare
NET
$93B
$2.23M 1.09%
40,259
+868
+2% +$51.6K
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$2.09M 1.02%
5,840
-157
-3% -$62.3K
GFS icon
31
GlobalFoundries
GFS
$29.4B
$2.04M 1%
+42,185
New +$2.27M
LRCX icon
32
Lam Research
LRCX
$382B
$1.86M 0.91%
50,890
-24,590
-33% -$1.09M
MA icon
33
Mastercard
MA
$477B
$1.75M 0.85%
6,136
-394
-6% -$131K
CVS icon
34
CVS Health
CVS
$137B
$1.72M 0.84%
18,055
-584
-3% -$57.8K
NVDA icon
35
NVIDIA
NVDA
$5.01T
$1.68M 0.82%
138,540
-126,170
-48% -$1.99M
CNQ icon
36
Canadian Natural Resources
CNQ
$96.9B
$1.65M 0.8%
70,796
-3,445
-5% -$89.2K
ADI icon
37
Analog Devices
ADI
$181B
$1.63M 0.79%
11,677
+9,253
+382% +$1.46M
CCI icon
38
Crown Castle
CCI
$32.7B
$1.62M 0.79%
11,227
-370
-3% -$63.3K
MOS icon
39
The Mosaic Company
MOS
$7.09B
$1.58M 0.77%
32,657
+9,471
+41% +$489K
PEP icon
40
PepsiCo
PEP
$186B
$1.46M 0.71%
8,926
+59
+0.7% +$10.2K
PODD icon
41
Insulet
PODD
$11.3B
$1.43M 0.7%
6,225
-139
-2% -$34.8K
HD icon
42
Home Depot
HD
$332B
$1.31M 0.64%
4,758
-422
-8% -$125K
TGT icon
43
Target
TGT
$62.1B
$1.24M 0.61%
+8,377
New +$1.34M
CRM icon
44
Salesforce
CRM
$134B
$1.24M 0.6%
8,612
-3,073
-26% -$521K
SYK icon
45
Stryker
SYK
$127B
$1.16M 0.57%
+5,738
New +$1.21M
MRO
46
DELISTED
Marathon Oil Corporation
MRO
$1.16M 0.56%
51,151
-112,113
-69% -$2.66M
MPC icon
47
Marathon Petroleum
MPC
$90.3B
$1.12M 0.55%
11,258
+946
+9% +$88.6K
CRWD icon
48
CrowdStrike
CRWD
$187B
$1.11M 0.54%
27,068
-9,432
-26% -$431K
BP icon
49
BP
BP
$113B
$1.02M 0.5%
35,749
-646
-2% -$19.2K
GOOG icon
50
Alphabet (Google) Class C
GOOG
$3.9T
$1.02M 0.5%
10,580

Similar funds

Jackson Square Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Jackson Square Capital held 155 positions worth $205M, down 13% from $237M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jackson Square Capital withdrew a net $25.1M in Q3 2022, closing 33 positions and reducing 54 holdings. Its most notable exit was Sierra Oncology, Inc. Common Stock, an estimated $5.55M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Energy.

Against the trend, Jackson Square Capital opened a new position in Synopsys worth $4M.

  • Jackson Square Capital's largest Q3 2022 buy was Synopsys: 13,078 shares worth $4M.
  • Jackson Square Capital added most to Analog Devices in Q3 2022, an estimated $1.46M increase.
  • Jackson Square Capital's biggest Q3 2022 reduction was Marathon Oil Corporation, cutting an estimated $2.66M.
  • Jackson Square Capital fully exited Sierra Oncology, Inc. Common Stock in Q3 2022, selling an estimated $5.55M.
  • Jackson Square Capital's ten largest holdings make up 37% of its $205M portfolio in Q3 2022.
  • Jackson Square Capital opened 17 new positions and closed 33 in Q3 2022.
  • Jackson Square Capital's portfolio value fell 13% quarter-over-quarter to $205M.

Based on Jackson Square Capital's 13F filing for Q3 2022, filed 13 Oct 2022.